ALLOFIT ALLOCLASSIC SHELL 52/I I
Report
- Report Number
- 0009613350-2017-01370
- Event Type
- Injury
- Date Received
- October 5, 2017
- Date of Event
- November 2, 2004
- Report Date
- March 20, 2018
- Manufacturer
- ZIMMER GMBH
- Product Code
- LZO
- PMA / PMN Number
- PK003758
- Removal / Correction Number
- N/A
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- ATTORNEY
Narratives
DUE TO FACT THAT THIS IS A LEGAL CLAIM, OUR LEGAL DEPARTMENT HAS BEEN PROVIDED WITH THE AVAILABLE FACTS FROM THE CUSTOMER. ZIMMER (B)(4) LEGAL DEPARTMENT IS WELL TRAINED AND PASSES ALL INFORMATION CONCERNING THE CASE TO OUR COMPLAINT HANDLING DEPARTMENT. AS SOON AS SUPPLEMENTAL INFORMATION BECOMES AVAILABLE AN UPDATED REPORT WILL BE SUBMITTED. THE MANUFACTURER DID NOT RECEIVE X-RAYS, OR OTHER SOURCE DOCUMENTS FOR REVIEW. THE MANUFACTURER DID NOT RECEIVE THE DEVICE FOR INVESTIGATION. THE DEVICE HISTORY RECORDS WERE REVIEWED AND FOUND TO BE CONFORMING. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND IS CURRENTLY NOT AVAILABLE. A CAUSE FOR THIS SPECIFIC EVENT CANNOT BE ASCERTAINED FROM THE INFORMATION PROVIDED. AS SOON AS SUPPLEMENTAL INFORMATION BECOMES AVAILABLE AN UPDATED REPORT WILL BE SUBMITTED. ZIMMER BIOMET¿S REFERENCE NUMBER OF THIS FILE IS (B)(4).
CONCOMITANT MEDICAL PRODUCTS: ZIMMER (B)(4) METASUL®, ALPHA INSERT, II/28, ITEM#01.00010.409, LOT#2212386 ZIMMER (B)(4): CLS® SPOTORNO®, STEM, 135°, UNCEMENTED, 10.0, TAPER 12/14, ITEM#29.00.39-100, LOT#2218074 ZIMMER INC.: METASUL HEAD 28/+4. THE DEVICE IS MANUFACTURED BY ZINMNER INC, WARSAW AND WILL BE REPORTED UNDER CASE NUMBER (B)(4). THE REPORT NUMBER IS CURRENTLY UNKNOWASTHE REPORT IS NOT YET SUBMITTED. TREND ANALYSIS: NO TREND CONSIDERING THE FOLLOWING EVENT IS IDENTIFIED: REVISION DUE TO INFECTION. DEVICE HISTORY RECORDS (DHR): THE DEVICE MANUFACTURING QUALITY RECORDS INDICATE THAT THE RELEASED COMPONENTS MET ALL REQUIREMENTS TO PERFORM AS INTENDED. EVENT DESCRIPTION (EVENT DETAILS, PER) - EVENT SUMMARY: PATIENT RECEIVED THE PRIMARY THA (ALLOFIT SHELL 52/II, METASUL ALPHA INSERT II/28, METASUL HEAD 28/+4 (WARSAW DESIGN, CMP-0376725 ), CLS STEM 135) FOR LEFT HIP ON OCT 6, 2004 AND UNDERWENT A REVISION SURGERY ON NOV 2, 2004 DUE TO INFECTION. ALL THE IMPLANTS WERE REVISED EXCEPT THE STEM. REVIEW OF RECEIVED DATA - PRIMARY IMPLANTATION SURGERY NOTES DATED (B)(6), 2004: - PRODUCTS IMPLANTED: ALLOFIT SHELL 52/II, METASUL ALPHA INSERT II/28, METASUL HEAD 28/+4 (WARSAW DESIGN, CMP-376725), CLS STEM 135 - NO SUSPICOUS EVENTS OBSERVED DURING THE SURGERY THAT MIGHT HAVE LED TO THE INFECTION REVISION SURGERY NOTES DATED (B)(6), 2004: ONE-STAGE REVISION OF LEFT THA DUE TO INFECTION - PRODUCTS REMOVED: ALLOFIT SHELL 52/II, METASUL ALPHA INSERT II/28, METASUL HEAD 28/+4 - THE CLS STEM 135 WAS EXPLANTED, STERILIZED, AND RE-IMPLANTED - NEW PRODUCTS IMPLANTED: ALLOFIT SHELL 54/JJ, METASUL ALPHA INSERT JJ/28, METASUL HEAD 28/+4 (WARSAW DESIGN, (B)(4)) - TISSUE SAMPLES WERE SENT FOR EXAMINATION DEVICES ANALYSIS NO PRODUCT WAS RETURNED TO ZIMMER BIOMET FOR IN-DEPTH ANALYSIS. ACCORDING TO THE INFORMATIO RECEIVED, THE PRODUCT LOCATION IS UNKNOWN. REVIEW OF PRODUCT DOCUMENTATION - THE COMPATIBILITY CHECK WAS PERFORMED FROM (B)(6) AND SHOWED THAT THE PRODUCT COMBINATION WAS APPROVED BY ZIMMER BIOMET - STERILIZATION CERTIFICATES OF THE IMPLANTS WERE REVIEWED AND CONFIRMED TO BE CONFORMING TO THE RESPECTIVE STERILIZATION SPECIFICATIONS. CONCLUSION SUMMARY FOR THE INVESTIGATION OF THE CASE SURGICAL REPORTS WITH THE IMPLANT STICKERS WERE RECEIVED. THE REVISION SURGERY REPORT DATED (B)(6), 2004 CONFIRMS THE EVENT OF INFECTION. ALL THE COMPONENTS EXCEPT THE STEM WERE REVISED. THE CLS STEM WAS REMOVED DURING THE SURGERY, CLEANED&RE-STERILIZED AND RE-IMPLANTED. STERILIZATION SPECIFICATIONS OF THE DEVICES CERTIFY THE SUITABILITY OF STERILIZATION. THE STERILIZATION CERTIFICATES ARE REVIEWED AND IT IS CONFIRMED THAT THE PRODUCTS WERE STERILIZED ACCORDING TO THE SPECIFICATIONS. SINGLE-USE, STERILIZED DEVICES MANUFACTURED OR DISTRIBUTED BY ZIMMER BIOMET ARE STERILIZED IN ACCORDANCE WITH FDA REGULATIONS AND ISO STANDARDS TO A STERILITY ASSURANCE LEVEL OF 1.0 X 10-6 OR BETTER. THEREFORE, IT IS NOT SUSPECTED THAT THE PRODUCT CAUSED OR CONTRIBUTED TO ANY PATIENT INFECTION. THEREFORE, IT CAN BE EXCLUDED THAT AN UNSTERILE DEVICE CAUSED THE INFECTION. POSSIBLE REASONS FOR THE INFECTION INCLUDE CONTAMINATION OF THE IMPLANTS DURING THE PRIMARY SURGERY, SECONDARY INFECTION, COMORBITITY (PATIENT HAVING AN INFECTION IN ANOTHER SITE OF THE BODY), REUSE OF SINGLE USE COMPONENTS AND FAIL OF RESTERILIZATION METHOD AS SUGGESTED IN IFU. HOWEVER, AN EXACT ROOT CAUSE COULD NOT BE DETERMINED. THE NEED FOR CORRECTIVE MEASURES IS NOT INDICATED AND ZIMMER BIOMET CONSIDERS THIS CASE AS CLOSED. ZIMMER BIOMET¿S REFERENCE NUMBER OF THIS FILE IS (B)(4). THE FOLLOWING REPORTS ARE ASSOCIATED WITH THIS EVENT:0009613350-2017-01371, 0009613350-2017-01373.
A PATIENT IS PURSUING A PRODUCT LIABILITY CLAIM. IT WAS REPORTED THAT THE PATIENT WAS IMPLANTED A ALLOFIT ALLOCLASSIC SHELL 52/I I ON THE LEFT SIDE ON (B)(6) 2004 AND THE PATIENT UNDERWENT REVISION SURGERY ON (B)(6) 2004 DUE TO INFECTION AND LOOSENING.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 696571 | ALLOFIT ALLOCLASSIC SHELL 52/I I | ALLOFIT ACETABULAR SYSTEM | LZO | ZIMMER GMBH | N/A | 2214665 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 31 YR | Hospitalization| R |